SARA WOLFORD: Open Payments
NPI 1649019795 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,162 in 49 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $273 · 2025 $2,162
Food & beverage: $2,069Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $389 |
| Gilead Sciences, Inc. | 7 | $291 |
| Janssen Biotech, Inc. | 3 | $145 |
| Immunocore Limited | 2 | $144 |
| E.R. Squibb & Sons, L.L.C. | 1 | $130 |
| Amgen Inc. | 1 | $125 |
| PharmaEssentia USA Corporation | 1 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| Lilly USA, LLC | 2 | $105 |
| Myriad Genetic Laboratories, Inc. | 1 | $79 |
Products named: Trodelvy, DATROWAY, KIMMTRAK, OPDIVO, RYBREVANT, IMDELLTRA (AMG757), BESREMI, IMFINZI.
Industry payments across VA — which companies pay providers there.
